Analysis of therapeutic effects on type II respiratory failure and impact on blood gas changes: high-flow nasal oxygen therapy vs. non-invasive positive pressure ventilation

CONCLUSION: HFNO demonstrates superior therapeutic efficacy in type II respiratory failure, significantly improving blood gas parameters with a high level of safety, supporting its clinical applicability.PMID:38463604 | PMC:PMC10918141 | DOI:10.62347/MUHL4407
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research